S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis

Proteomics - Clinical Applications

Volumn 6, Issue 3-4, 2012, Pages 152-162

  Wu, Wei ^a   Juan, Wen Chun ^a   Liang, Cynthia R M Y ^b   Yeoh, Khay Guan ^c   So, Jimmy ^b   Chung, Maxey C M ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

AAT; Combinatorial biomarkers; GIF; S100A9

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CALGRANULIN B; INTRINSIC FACTOR; PROTEOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; GASTRITIS; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; STOMACH JUICE; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; BLOTTING, WESTERN; BODY FLUIDS; CALGRANULIN B; EARLY DETECTION OF CANCER; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GASTRITIS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860322118     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201100050     Document Type: Article

References (59)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., et al., Cancer statistics, 2009. C.A. Cancer J. Clin. 2009, 59, 225-249.
2. Cancer Facts & Figures 2009. Am. Cancer Soc. 2009, .
3. Green, P. H., O'Toole, K. M., Slonim, D., Wang, T., et al., Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am. J. Med. 1988, 85, 658-661.
4. Hundahl, S. A., Stemmermann, G. N., Oishi, A., Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch. Surg. 1996, 131, 170-175.
5. Voutilainen, M. E., Juhola, M. T., Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur. J. Gastroenterol. Hepatol. 2005, 17, 1345-1349.
6. Amin, A., Gilmour, H., Graham, L., Paterson-Brown, S., et al., Gastric adenocarcinoma missed at endoscopy. J. R. Coll. Surg. Edinb. 2002, 47, 681-684.
7. Wang, N., Wilkin, C., Bocking, A., Tribukait, B., Evaluation of tumor heterogeneity of prostate carcinoma by flow- and image DNA cytometry and histopathological grading. Anal. Cell. Pathol. 2000, 20, 49-62.
8. Wang, K., Li, J., Li, S., Bolund, L., et al., Estimation of tumor heterogeneity using CGH array data. BMC Bioinformatics 2009, 10, 12.
9. Prescott, J. W., Zhang, D., Wang, J. Z., Mayr, N. A., et al., Temporal analysis of tumor heterogeneity and volume for cervical cancer treatment outcome prediction: preliminary evaluation. J. Digit. Imaging 2010, 23, 342-357.
10. Liu, J., Lau, S. K., Varma, V. A., Moffitt, R. A., et al., Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano 2010, 4, 2755-2765.
11. Verma, M., Srivastava, S., New cancer biomarkers deriving from NCI early detection research. Recent Res. Cancer Res. 2003, 163, 72-84; discussion 264-266.
12. Lam, K. W. K., Lo, S. C. L., Discovery of diagnostic serum biomarkers of gastric cancer using proteomics. Proteomics Clin. Appl. 2008, 2, 219-228.
13. Ge, C., Ma, N., Yao, D., Luan, F., et al., A serum biomarker model to diagnose pancreatic cancer using proteomic fingerprint technology. Chin. J. Clin. Oncol. 2008, 5, 200-205.
14. Makarov, D. V., Loeb, S., Getzenberg, R. H., et al., Biomarkers for prostate cancer. Annu. Rev. Med. 2009, 60, 139-151.
15. Duraker, N., Celik, A. N., The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J. Surg. Oncol. 2001, 76, 266-271.
16. Tocchi, A., Costa, G., Lepre, L., Liotta, G., et al., The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J. Cancer Res. Clin. Oncol. 1998, 124, 450-455.
17. Mattar, R., Alves de Andrade, C. R., DiFavero, G. M., Gama-Rodrigues, J. J., et al., Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev. Hosp. Clin. Fac. Med. Sao Paulo 2002, 57, 89-92.
18. Tan, S., Liang, C., Yeoh, K. G., So, J., et al., Gastrointestinal fluids proteomics. Proteomics Clin. Appl. 2007, 1, 820-833.
19. Veenstra, T. D., Conrads, T. P., Hood, B. L., Avellino, A. M., et al., Biomarkers: mining the biofluid proteome. Mol. Cell. Proteomics 2005, 4, 409-418.
20. Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J. L., et al., Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J. Proteome Res. 2007, 6, 4549-4555.
21. Hsu, P. I., Chen, C. H., Hsieh, C. S., Chang, W. C., et al., Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin. Cancer Res. 2007, 13, 876-883.
22. Kon, O. L., Yip, T. T., Ho, M. F., Chan, W. H., et al., The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med. Genomics 2008, 1, 54.
23. Liang, C. R., Leow, C. K., Neo, J. C., Tan, G. S., et al., Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005, 5, 2258-2271.
24. Neo, J. C., Rose, P., Ong, C. N., Chung, M. C., Beta-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics 2005, 5, 1075-1082.
25. Tan, H. T., Tan, S., Lin, Q., Lim, T. K., et al., Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells. Mol. Cell. Proteomics 2008, 7, 1174-1185.
26. Liang, C. R., Tan, S., Tan, H. T., Lin, Q., et al., Proteomic analysis of human gastric juice: a shotgun approach. Proteomics 2010, 10, 3928-3931.
27. Chang, W. C., Hsu, P. I., Chen, Y. Y., Hsiao, M., et al., Observation of peptide differences between cancer and control in gastric juice. Proteomics Clin. Appl. 2008, 2, 55-62.
28. Donato, R., S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 2001, 33, 637-668.
29. Marenholz, I., Heizmann, C. W., Fritz, G., S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Bioph. Res. Co. 2004, 322, 1111-1122.
30. Schafer, B. W., Heizmann, C. W., The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21, 134-140.
31. Yong, H. Y., Moon, A., Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 2007, 30, 75-81.
32. Heizmann, C. W., Fritz, G., Schafer, B. W., S100 proteins: structure, functions and pathology. Front Biosci. 2002, 7, d1356-d1368.
33. Hermani, A., De Servi, B., Medunjanin, S., Tessier, P. A., et al., S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 2006, 312, 184-197.
34. Muller, H., Haug, U., Rothenbacher, D., Stegmaier, C., et al., Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer. J. Urol. 2008, 180, 1309-1312; discussion 1312-1303.
35. Nemeth, J., Stein, I., Haag, D., Riehl, A., et al., S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 2009, 50, 1251-1262.
36. Levine, J. S., Nakane, P. K., Allen, R. H., Human intrinsic factor secretion: immunocytochemical demonstration of membrane-associated vesicular transport in parietal cells. J. Cell Biol. 1981, 90, 644-655.
37. Yang, Y. M., Ducos, R., Rosenberg, A. J., Catrou, P. G., et al., Cobalamin malabsorption in three siblings due to an abnormal intrinsic factor that is markedly susceptible to acid and proteolysis. J. Clin. Invest. 1985, 76, 2057-2065.
38. Hvas, A. M., Buhl, H., Laursen, N. B., Hesse, B., et al., The effect of recombinant human intrinsic factor on the uptake of vitamin B12 in patients with evident vitamin B12 deficiency. Haematologica 2006, 91, 805-808.
39. Ahn, M. J., Han, D., Park, Y. J., Park, G. T., et al., A case of type IIa early gastric cancer developed in pernicious anemia. J. Korean Med. Sci. 1998, 13, 81-84.
40. Tanner, S. M., Li, Z., Perko, J. D., Oner, C., et al., Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. Proc. Natl. Acad. Sci. USA 2005, 102, 4130-4133.
41. Yassin, F., Rothenberg, S. P., Rao, S., Gordon, M. M., et al., Identification of a 4-base deletion in the gene in inherited intrinsic factor deficiency. Blood 2004, 103, 1515-1517.
42. Chan, E. D., Kaminska, A. M., Gill, W., Chmura, K., et al., Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand. J. Infect. Dis. 2007, 39, 690-696.
43. El-Akawi, Z. J., Al-Hindawi, F. K., Bashir, N. A., Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients. Neuroendocrinol. Lett. 2008, 29, 482-484.
44. Kloth, J. N., Gorter, A., Fleuren, G. J., Oosting, J., et al., Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J. Pathol. 2008, 215, 222-230.
45. Thakur, A., Bollig, A., Wu, J., Liao, D. J., Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. Mol. Cancer 2008, 7, 11.
46. Wang, M., Long, R. E., Comunale, M. A., Junaidi, O., et al., Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidem. Biomar. Prev. 2009, 18, 1914-1921.
47. Hamrita, B., Chahed, K., Trimeche, M., Guillier, C. L., et al., Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin. Chim. Acta. 2009, 404, 111-118.
48. El-Rifai, W., Moskaluk, C. A., Abdrabbo, M. K., Harper, J., et al., Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 2002, 62, 6823-6826.
49. Gebhardt, C., Nemeth, J., Angel, P., Hess, J., S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 2006, 72, 1622-1631.
50. Ryckman, C., Vandal, K., Rouleau, P., Talbot, M., et al., Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 2003, 170, 3233-3242.
51. Roth, J., Vogl, T., Sorg, C., Sunderkotter, C., Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 2003, 24, 155-158.
52. Chanarin, I., Intrinsic factor. Clin. Chim. Acta 1968, 22, 85-90.
53. Huang, H., Campbell, S. C., Nelius, T., Bedford, D. F., et al., Alpha1-antitrypsin inhibits angiogenesis and tumor growth. Int. J. Cancer 2004, 112, 1042-1048.
54. Lee, K., Kye, M., Jang, J. S., Lee, O. J., et al., Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics 2004, 4, 3343-3352.
55. Chen, J., Kahne, T., Rocken, C., Gotze, T., et al., Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J. Proteome Res. 2004, 3, 1009-1016.
56. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T., et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
57. Ryu, J. W., Kim, H. J., Lee, Y. S., Myong, N. H., et al., The proteomics approach to find biomarkers in gastric cancer. J. Korean Med. Sci. 2003, 18, 505-509.
58. Fregonese, L., Stolk, J., Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J. Rare Dis. 2008, 3, 16.
59. Muretto, P., Graziano, F., Staccioli, M. P., Barbanti, I., et al., An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool. Ann. Oncol. 2003, 14, 105-109.